awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35208151-2D8AAB7A-9F9E-4A91-9D57-0EFB6AB559BE
Q35208151-2D8AAB7A-9F9E-4A91-9D57-0EFB6AB559BE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35208151-2D8AAB7A-9F9E-4A91-9D57-0EFB6AB559BE
Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction
P2860
Q35208151-2D8AAB7A-9F9E-4A91-9D57-0EFB6AB559BE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35208151-2D8AAB7A-9F9E-4A91-9D57-0EFB6AB559BE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7a8146cf621b7829cd6422eabee107d001f4c936
P2860
A novel pharmacodynamic approach to assess and predict tumor response to the epidermal growth factor receptor inhibitor gefitinib in patients with esophageal cancer